nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—endothelium—colon cancer	0.0273	0.0756	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—colon cancer	0.0259	0.896	CrCbGaD
Pentoxifylline—PDE5A—blood vessel—colon cancer	0.0252	0.0697	CbGeAlD
Pentoxifylline—NT5E—embryo—colon cancer	0.0231	0.0641	CbGeAlD
Pentoxifylline—NT5E—epithelium—colon cancer	0.0189	0.0523	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—colon cancer	0.0182	0.0504	CbGeAlD
Pentoxifylline—NT5E—renal system—colon cancer	0.0175	0.0485	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—colon cancer	0.0156	0.0431	CbGeAlD
Pentoxifylline—NT5E—lymphoid tissue—colon cancer	0.0145	0.0403	CbGeAlD
Pentoxifylline—NT5E—bone marrow—colon cancer	0.0132	0.0367	CbGeAlD
Pentoxifylline—NT5E—vagina—colon cancer	0.0127	0.0351	CbGeAlD
Pentoxifylline—PDE5A—epithelium—colon cancer	0.0123	0.0339	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—colon cancer	0.0118	0.0327	CbGeAlD
Pentoxifylline—PDE5A—renal system—colon cancer	0.0114	0.0315	CbGeAlD
Pentoxifylline—ADORA2B—vagina—colon cancer	0.0109	0.0301	CbGeAlD
Pentoxifylline—ADORA1—renal system—colon cancer	0.0108	0.0298	CbGeAlD
Pentoxifylline—NT5E—liver—colon cancer	0.0107	0.0296	CbGeAlD
Pentoxifylline—ADORA2A—lymphoid tissue—colon cancer	0.0104	0.0287	CbGeAlD
Pentoxifylline—PDE5A—digestive system—colon cancer	0.00932	0.0258	CbGeAlD
Pentoxifylline—PDE5A—vagina—colon cancer	0.00823	0.0228	CbGeAlD
Pentoxifylline—NT5E—lymph node—colon cancer	0.0082	0.0227	CbGeAlD
Pentoxifylline—ADORA1—vagina—colon cancer	0.0078	0.0216	CbGeAlD
Pentoxifylline—ADORA2A—liver—colon cancer	0.00762	0.0211	CbGeAlD
Pentoxifylline—PDE4B—lymphoid tissue—colon cancer	0.00662	0.0183	CbGeAlD
Pentoxifylline—PDE4A—lymph node—colon cancer	0.00626	0.0173	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—colon cancer	0.00603	0.0167	CbGeAlD
Pentoxifylline—PDE4B—vagina—colon cancer	0.00577	0.016	CbGeAlD
Pentoxifylline—PDE5A—lymph node—colon cancer	0.00532	0.0147	CbGeAlD
Pentoxifylline—ADORA1—lymph node—colon cancer	0.00505	0.014	CbGeAlD
Pentoxifylline—CYP1A2—renal system—colon cancer	0.00489	0.0136	CbGeAlD
Pentoxifylline—PDE4B—liver—colon cancer	0.00487	0.0135	CbGeAlD
Pentoxifylline—CYP1A2—digestive system—colon cancer	0.00401	0.0111	CbGeAlD
Pentoxifylline—PDE4B—lymph node—colon cancer	0.00373	0.0103	CbGeAlD
Pentoxifylline—Pancytopenia—Vincristine—colon cancer	0.0036	0.00606	CcSEcCtD
Pentoxifylline—Angina pectoris—Irinotecan—colon cancer	0.0036	0.00605	CcSEcCtD
Pentoxifylline—Angina pectoris—Fluorouracil—colon cancer	0.00344	0.0058	CcSEcCtD
Pentoxifylline—Pancytopenia—Fluorouracil—colon cancer	0.00336	0.00565	CcSEcCtD
Pentoxifylline—Ear pain—Capecitabine—colon cancer	0.00335	0.00564	CcSEcCtD
Pentoxifylline—Sleep disorder—Capecitabine—colon cancer	0.0033	0.00556	CcSEcCtD
Pentoxifylline—Swelling—Capecitabine—colon cancer	0.00324	0.00545	CcSEcCtD
Pentoxifylline—Sweating—Vincristine—colon cancer	0.00324	0.00545	CcSEcCtD
Pentoxifylline—Jaundice—Irinotecan—colon cancer	0.00321	0.0054	CcSEcCtD
Pentoxifylline—Vascular purpura—Capecitabine—colon cancer	0.0032	0.00538	CcSEcCtD
Pentoxifylline—Sweating—Irinotecan—colon cancer	0.00316	0.00531	CcSEcCtD
Pentoxifylline—Infestation NOS—Fluorouracil—colon cancer	0.00315	0.00531	CcSEcCtD
Pentoxifylline—Infestation—Fluorouracil—colon cancer	0.00315	0.00531	CcSEcCtD
Pentoxifylline—Conjunctivitis—Fluorouracil—colon cancer	0.00306	0.00516	CcSEcCtD
Pentoxifylline—Caffeine—ABCB1—colon cancer	0.00302	0.105	CrCbGaD
Pentoxifylline—Thirst—Capecitabine—colon cancer	0.003	0.00505	CcSEcCtD
Pentoxifylline—CYP1A2—liver—colon cancer	0.00299	0.00828	CbGeAlD
Pentoxifylline—Epistaxis—Fluorouracil—colon cancer	0.00297	0.005	CcSEcCtD
Pentoxifylline—Haemoglobin—Irinotecan—colon cancer	0.00297	0.005	CcSEcCtD
Pentoxifylline—Purpura—Capecitabine—colon cancer	0.00297	0.00499	CcSEcCtD
Pentoxifylline—Haemorrhage—Irinotecan—colon cancer	0.00296	0.00497	CcSEcCtD
Pentoxifylline—Haemoglobin—Fluorouracil—colon cancer	0.00284	0.00479	CcSEcCtD
Pentoxifylline—Haemorrhage—Fluorouracil—colon cancer	0.00283	0.00476	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Methotrexate—colon cancer	0.00275	0.00463	CcSEcCtD
Pentoxifylline—Flushing—Irinotecan—colon cancer	0.00274	0.00461	CcSEcCtD
Pentoxifylline—Immune system disorder—Irinotecan—colon cancer	0.00267	0.00449	CcSEcCtD
Pentoxifylline—Arrhythmia—Irinotecan—colon cancer	0.00264	0.00444	CcSEcCtD
Pentoxifylline—Back pain—Vincristine—colon cancer	0.00256	0.0043	CcSEcCtD
Pentoxifylline—Flatulence—Irinotecan—colon cancer	0.00254	0.00427	CcSEcCtD
Pentoxifylline—Arrhythmia—Fluorouracil—colon cancer	0.00253	0.00425	CcSEcCtD
Pentoxifylline—Back pain—Irinotecan—colon cancer	0.00249	0.00419	CcSEcCtD
Pentoxifylline—Abdominal distension—Capecitabine—colon cancer	0.00249	0.00419	CcSEcCtD
Pentoxifylline—Muscle spasms—Irinotecan—colon cancer	0.00247	0.00416	CcSEcCtD
Pentoxifylline—Erythema—Fluorouracil—colon cancer	0.00246	0.00415	CcSEcCtD
Pentoxifylline—Anaemia—Vincristine—colon cancer	0.00244	0.00411	CcSEcCtD
Pentoxifylline—Bronchospasm—Capecitabine—colon cancer	0.00243	0.00409	CcSEcCtD
Pentoxifylline—Agitation—Vincristine—colon cancer	0.00243	0.00408	CcSEcCtD
Pentoxifylline—Angina pectoris—Capecitabine—colon cancer	0.00241	0.00405	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Irinotecan—colon cancer	0.00239	0.00402	CcSEcCtD
Pentoxifylline—Anaemia—Irinotecan—colon cancer	0.00238	0.004	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Capecitabine—colon cancer	0.00237	0.00399	CcSEcCtD
Pentoxifylline—Leukopenia—Vincristine—colon cancer	0.00236	0.00398	CcSEcCtD
Pentoxifylline—Pancytopenia—Capecitabine—colon cancer	0.00235	0.00395	CcSEcCtD
Pentoxifylline—Vision blurred—Fluorouracil—colon cancer	0.00232	0.00391	CcSEcCtD
Pentoxifylline—Malaise—Irinotecan—colon cancer	0.00232	0.0039	CcSEcCtD
Pentoxifylline—Leukopenia—Irinotecan—colon cancer	0.0023	0.00387	CcSEcCtD
Pentoxifylline—Convulsion—Vincristine—colon cancer	0.00229	0.00385	CcSEcCtD
Pentoxifylline—Hypertension—Vincristine—colon cancer	0.00228	0.00384	CcSEcCtD
Pentoxifylline—Anaemia—Fluorouracil—colon cancer	0.00228	0.00383	CcSEcCtD
Pentoxifylline—Myalgia—Vincristine—colon cancer	0.00225	0.00378	CcSEcCtD
Pentoxifylline—Hypertension—Irinotecan—colon cancer	0.00222	0.00374	CcSEcCtD
Pentoxifylline—Leukopenia—Fluorouracil—colon cancer	0.00221	0.00371	CcSEcCtD
Pentoxifylline—Infestation—Capecitabine—colon cancer	0.0022	0.00371	CcSEcCtD
Pentoxifylline—Infestation NOS—Capecitabine—colon cancer	0.0022	0.00371	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Methotrexate—colon cancer	0.0022	0.0037	CcSEcCtD
Pentoxifylline—Discomfort—Irinotecan—colon cancer	0.00216	0.00364	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Vincristine—colon cancer	0.00216	0.00363	CcSEcCtD
Pentoxifylline—Oedema—Vincristine—colon cancer	0.00216	0.00363	CcSEcCtD
Pentoxifylline—Jaundice—Capecitabine—colon cancer	0.00215	0.00361	CcSEcCtD
Pentoxifylline—Infection—Vincristine—colon cancer	0.00214	0.0036	CcSEcCtD
Pentoxifylline—Conjunctivitis—Capecitabine—colon cancer	0.00214	0.0036	CcSEcCtD
Pentoxifylline—Convulsion—Fluorouracil—colon cancer	0.00213	0.00359	CcSEcCtD
Pentoxifylline—Confusional state—Irinotecan—colon cancer	0.00212	0.00356	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Vincristine—colon cancer	0.00211	0.00355	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Irinotecan—colon cancer	0.0021	0.00353	CcSEcCtD
Pentoxifylline—Oedema—Irinotecan—colon cancer	0.0021	0.00353	CcSEcCtD
Pentoxifylline—Chest pain—Fluorouracil—colon cancer	0.0021	0.00353	CcSEcCtD
Pentoxifylline—Myalgia—Fluorouracil—colon cancer	0.0021	0.00353	CcSEcCtD
Pentoxifylline—Infection—Irinotecan—colon cancer	0.00209	0.00351	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Vincristine—colon cancer	0.00208	0.00351	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Capecitabine—colon cancer	0.00208	0.00351	CcSEcCtD
Pentoxifylline—Epistaxis—Capecitabine—colon cancer	0.00208	0.0035	CcSEcCtD
Pentoxifylline—Discomfort—Fluorouracil—colon cancer	0.00207	0.00349	CcSEcCtD
Pentoxifylline—Shock—Irinotecan—colon cancer	0.00207	0.00348	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Irinotecan—colon cancer	0.00206	0.00346	CcSEcCtD
Pentoxifylline—Anorexia—Vincristine—colon cancer	0.00206	0.00346	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Irinotecan—colon cancer	0.00203	0.00342	CcSEcCtD
Pentoxifylline—Confusional state—Fluorouracil—colon cancer	0.00203	0.00341	CcSEcCtD
Pentoxifylline—Hypotension—Vincristine—colon cancer	0.00201	0.00339	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Fluorouracil—colon cancer	0.00201	0.00338	CcSEcCtD
Pentoxifylline—Oedema—Fluorouracil—colon cancer	0.00201	0.00338	CcSEcCtD
Pentoxifylline—Anorexia—Irinotecan—colon cancer	0.002	0.00337	CcSEcCtD
Pentoxifylline—Infection—Fluorouracil—colon cancer	0.002	0.00336	CcSEcCtD
Pentoxifylline—Haemoglobin—Capecitabine—colon cancer	0.00199	0.00334	CcSEcCtD
Pentoxifylline—Hepatitis—Capecitabine—colon cancer	0.00198	0.00333	CcSEcCtD
Pentoxifylline—Haemorrhage—Capecitabine—colon cancer	0.00198	0.00333	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Fluorouracil—colon cancer	0.00197	0.00331	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Vincristine—colon cancer	0.00196	0.0033	CcSEcCtD
Pentoxifylline—Tachycardia—Fluorouracil—colon cancer	0.00196	0.0033	CcSEcCtD
Pentoxifylline—Hypotension—Irinotecan—colon cancer	0.00196	0.0033	CcSEcCtD
Pentoxifylline—Insomnia—Vincristine—colon cancer	0.00195	0.00328	CcSEcCtD
Pentoxifylline—Anorexia—Fluorouracil—colon cancer	0.00192	0.00323	CcSEcCtD
Pentoxifylline—Insomnia—Irinotecan—colon cancer	0.0019	0.0032	CcSEcCtD
Pentoxifylline—Hypotension—Fluorouracil—colon cancer	0.00188	0.00316	CcSEcCtD
Pentoxifylline—Decreased appetite—Vincristine—colon cancer	0.00187	0.00315	CcSEcCtD
Pentoxifylline—Dyspnoea—Irinotecan—colon cancer	0.00187	0.00315	CcSEcCtD
Pentoxifylline—Somnolence—Irinotecan—colon cancer	0.00187	0.00314	CcSEcCtD
Pentoxifylline—Dyspepsia—Irinotecan—colon cancer	0.00185	0.00311	CcSEcCtD
Pentoxifylline—Constipation—Vincristine—colon cancer	0.00184	0.0031	CcSEcCtD
Pentoxifylline—Flushing—Capecitabine—colon cancer	0.00184	0.00309	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00183	0.00308	CcSEcCtD
Pentoxifylline—Decreased appetite—Irinotecan—colon cancer	0.00183	0.00307	CcSEcCtD
Pentoxifylline—Insomnia—Fluorouracil—colon cancer	0.00182	0.00306	CcSEcCtD
Pentoxifylline—Constipation—Irinotecan—colon cancer	0.0018	0.00302	CcSEcCtD
Pentoxifylline—Dyspnoea—Fluorouracil—colon cancer	0.00179	0.00302	CcSEcCtD
Pentoxifylline—Somnolence—Fluorouracil—colon cancer	0.00179	0.00301	CcSEcCtD
Pentoxifylline—Immune system disorder—Capecitabine—colon cancer	0.00179	0.00301	CcSEcCtD
Pentoxifylline—Dyspepsia—Fluorouracil—colon cancer	0.00177	0.00298	CcSEcCtD
Pentoxifylline—Arrhythmia—Capecitabine—colon cancer	0.00177	0.00297	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—colon cancer	0.00176	0.00297	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Vincristine—colon cancer	0.00176	0.00297	CcSEcCtD
Pentoxifylline—Decreased appetite—Fluorouracil—colon cancer	0.00175	0.00294	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—colon cancer	0.00175	0.00294	CcSEcCtD
Pentoxifylline—Feeling abnormal—Irinotecan—colon cancer	0.00173	0.00291	CcSEcCtD
Pentoxifylline—Erythema—Capecitabine—colon cancer	0.00172	0.0029	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Irinotecan—colon cancer	0.00172	0.00289	CcSEcCtD
Pentoxifylline—Abdominal pain—Vincristine—colon cancer	0.0017	0.00287	CcSEcCtD
Pentoxifylline—Body temperature increased—Vincristine—colon cancer	0.0017	0.00287	CcSEcCtD
Pentoxifylline—Flatulence—Capecitabine—colon cancer	0.0017	0.00285	CcSEcCtD
Pentoxifylline—Dysgeusia—Capecitabine—colon cancer	0.00169	0.00284	CcSEcCtD
Pentoxifylline—Back pain—Capecitabine—colon cancer	0.00167	0.0028	CcSEcCtD
Pentoxifylline—Body temperature increased—Irinotecan—colon cancer	0.00166	0.00279	CcSEcCtD
Pentoxifylline—Abdominal pain—Irinotecan—colon cancer	0.00166	0.00279	CcSEcCtD
Pentoxifylline—Feeling abnormal—Fluorouracil—colon cancer	0.00166	0.00279	CcSEcCtD
Pentoxifylline—Muscle spasms—Capecitabine—colon cancer	0.00166	0.00279	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—colon cancer	0.00164	0.00276	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—colon cancer	0.00164	0.00276	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—colon cancer	0.00164	0.00276	CcSEcCtD
Pentoxifylline—Vision blurred—Capecitabine—colon cancer	0.00162	0.00273	CcSEcCtD
Pentoxifylline—Tremor—Capecitabine—colon cancer	0.00161	0.00271	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Capecitabine—colon cancer	0.0016	0.00269	CcSEcCtD
Pentoxifylline—Urticaria—Fluorouracil—colon cancer	0.0016	0.00269	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—colon cancer	0.00159	0.00268	CcSEcCtD
Pentoxifylline—Anaemia—Capecitabine—colon cancer	0.00159	0.00268	CcSEcCtD
Pentoxifylline—Body temperature increased—Fluorouracil—colon cancer	0.00159	0.00267	CcSEcCtD
Pentoxifylline—Hypersensitivity—Vincristine—colon cancer	0.00159	0.00267	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—colon cancer	0.00157	0.00265	CcSEcCtD
Pentoxifylline—Malaise—Capecitabine—colon cancer	0.00155	0.00261	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—colon cancer	0.00155	0.00261	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—colon cancer	0.00155	0.0026	CcSEcCtD
Pentoxifylline—Hypersensitivity—Irinotecan—colon cancer	0.00155	0.0026	CcSEcCtD
Pentoxifylline—Asthenia—Vincristine—colon cancer	0.00155	0.0026	CcSEcCtD
Pentoxifylline—Leukopenia—Capecitabine—colon cancer	0.00154	0.00259	CcSEcCtD
Pentoxifylline—Palpitations—Capecitabine—colon cancer	0.00152	0.00256	CcSEcCtD
Pentoxifylline—Asthenia—Irinotecan—colon cancer	0.00151	0.00253	CcSEcCtD
Pentoxifylline—Hypertension—Capecitabine—colon cancer	0.00149	0.0025	CcSEcCtD
Pentoxifylline—Hypersensitivity—Fluorouracil—colon cancer	0.00148	0.00249	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—colon cancer	0.00148	0.00249	CcSEcCtD
Pentoxifylline—Diarrhoea—Vincristine—colon cancer	0.00148	0.00248	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—colon cancer	0.00147	0.00248	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—colon cancer	0.00147	0.00248	CcSEcCtD
Pentoxifylline—Myalgia—Capecitabine—colon cancer	0.00147	0.00247	CcSEcCtD
Pentoxifylline—Chest pain—Capecitabine—colon cancer	0.00147	0.00247	CcSEcCtD
Pentoxifylline—Anxiety—Capecitabine—colon cancer	0.00146	0.00246	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00146	0.00245	CcSEcCtD
Pentoxifylline—Discomfort—Capecitabine—colon cancer	0.00145	0.00244	CcSEcCtD
Pentoxifylline—Diarrhoea—Irinotecan—colon cancer	0.00144	0.00242	CcSEcCtD
Pentoxifylline—Dry mouth—Capecitabine—colon cancer	0.00143	0.00241	CcSEcCtD
Pentoxifylline—Dizziness—Vincristine—colon cancer	0.00143	0.0024	CcSEcCtD
Pentoxifylline—Pruritus—Fluorouracil—colon cancer	0.00142	0.00239	CcSEcCtD
Pentoxifylline—Confusional state—Capecitabine—colon cancer	0.00142	0.00238	CcSEcCtD
Pentoxifylline—Oedema—Capecitabine—colon cancer	0.00141	0.00236	CcSEcCtD
Pentoxifylline—Infection—Capecitabine—colon cancer	0.0014	0.00235	CcSEcCtD
Pentoxifylline—Dizziness—Irinotecan—colon cancer	0.00139	0.00234	CcSEcCtD
Pentoxifylline—Shock—Capecitabine—colon cancer	0.00138	0.00233	CcSEcCtD
Pentoxifylline—Diarrhoea—Fluorouracil—colon cancer	0.00138	0.00232	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Capecitabine—colon cancer	0.00138	0.00232	CcSEcCtD
Pentoxifylline—Tachycardia—Capecitabine—colon cancer	0.00137	0.00231	CcSEcCtD
Pentoxifylline—Vomiting—Vincristine—colon cancer	0.00137	0.00231	CcSEcCtD
Pentoxifylline—Skin disorder—Capecitabine—colon cancer	0.00136	0.0023	CcSEcCtD
Pentoxifylline—Rash—Vincristine—colon cancer	0.00136	0.00229	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Capecitabine—colon cancer	0.00136	0.00229	CcSEcCtD
Pentoxifylline—Dermatitis—Vincristine—colon cancer	0.00136	0.00229	CcSEcCtD
Pentoxifylline—Headache—Vincristine—colon cancer	0.00135	0.00227	CcSEcCtD
Pentoxifylline—Anorexia—Capecitabine—colon cancer	0.00134	0.00225	CcSEcCtD
Pentoxifylline—Vomiting—Irinotecan—colon cancer	0.00133	0.00225	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—colon cancer	0.00133	0.00224	CcSEcCtD
Pentoxifylline—Dizziness—Fluorouracil—colon cancer	0.00133	0.00224	CcSEcCtD
Pentoxifylline—Rash—Irinotecan—colon cancer	0.00132	0.00223	CcSEcCtD
Pentoxifylline—Dermatitis—Irinotecan—colon cancer	0.00132	0.00223	CcSEcCtD
Pentoxifylline—Headache—Irinotecan—colon cancer	0.00132	0.00221	CcSEcCtD
Pentoxifylline—Hypotension—Capecitabine—colon cancer	0.00131	0.00221	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—colon cancer	0.00128	0.00216	CcSEcCtD
Pentoxifylline—Nausea—Vincristine—colon cancer	0.00128	0.00215	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00128	0.00215	CcSEcCtD
Pentoxifylline—Vomiting—Fluorouracil—colon cancer	0.00128	0.00215	CcSEcCtD
Pentoxifylline—Insomnia—Capecitabine—colon cancer	0.00127	0.00214	CcSEcCtD
Pentoxifylline—Rash—Fluorouracil—colon cancer	0.00127	0.00213	CcSEcCtD
Pentoxifylline—Dermatitis—Fluorouracil—colon cancer	0.00127	0.00213	CcSEcCtD
Pentoxifylline—Headache—Fluorouracil—colon cancer	0.00126	0.00212	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—colon cancer	0.00126	0.00211	CcSEcCtD
Pentoxifylline—Dyspnoea—Capecitabine—colon cancer	0.00125	0.00211	CcSEcCtD
Pentoxifylline—Nausea—Irinotecan—colon cancer	0.00125	0.0021	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—colon cancer	0.00124	0.00209	CcSEcCtD
Pentoxifylline—Dyspepsia—Capecitabine—colon cancer	0.00124	0.00208	CcSEcCtD
Pentoxifylline—Decreased appetite—Capecitabine—colon cancer	0.00122	0.00206	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—colon cancer	0.00121	0.00203	CcSEcCtD
Pentoxifylline—Constipation—Capecitabine—colon cancer	0.0012	0.00202	CcSEcCtD
Pentoxifylline—Nausea—Fluorouracil—colon cancer	0.00119	0.00201	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—colon cancer	0.00119	0.002	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—colon cancer	0.00118	0.00199	CcSEcCtD
Pentoxifylline—Feeling abnormal—Capecitabine—colon cancer	0.00116	0.00195	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—colon cancer	0.00116	0.00194	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Capecitabine—colon cancer	0.00115	0.00193	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—colon cancer	0.00115	0.00193	CcSEcCtD
Pentoxifylline—Urticaria—Capecitabine—colon cancer	0.00112	0.00188	CcSEcCtD
Pentoxifylline—Body temperature increased—Capecitabine—colon cancer	0.00111	0.00187	CcSEcCtD
Pentoxifylline—Abdominal pain—Capecitabine—colon cancer	0.00111	0.00187	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—colon cancer	0.00111	0.00187	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—colon cancer	0.00109	0.00184	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—colon cancer	0.00109	0.00184	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00108	0.00182	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—colon cancer	0.00108	0.00181	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—colon cancer	0.00105	0.00177	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—colon cancer	0.00105	0.00176	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—colon cancer	0.00104	0.00175	CcSEcCtD
Pentoxifylline—Hypersensitivity—Capecitabine—colon cancer	0.00104	0.00174	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—colon cancer	0.00102	0.00172	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—colon cancer	0.00102	0.00171	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—colon cancer	0.00101	0.0017	CcSEcCtD
Pentoxifylline—Asthenia—Capecitabine—colon cancer	0.00101	0.0017	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—colon cancer	0.000997	0.00168	CcSEcCtD
Pentoxifylline—Pruritus—Capecitabine—colon cancer	0.000994	0.00167	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—colon cancer	0.000978	0.00164	CcSEcCtD
Pentoxifylline—Diarrhoea—Capecitabine—colon cancer	0.000961	0.00162	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000953	0.0016	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—colon cancer	0.000946	0.00159	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—colon cancer	0.000933	0.00157	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—colon cancer	0.00093	0.00156	CcSEcCtD
Pentoxifylline—Dizziness—Capecitabine—colon cancer	0.000929	0.00156	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—colon cancer	0.000921	0.00155	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—colon cancer	0.000909	0.00153	CcSEcCtD
Pentoxifylline—Vomiting—Capecitabine—colon cancer	0.000893	0.0015	CcSEcCtD
Pentoxifylline—Rash—Capecitabine—colon cancer	0.000886	0.00149	CcSEcCtD
Pentoxifylline—Dermatitis—Capecitabine—colon cancer	0.000885	0.00149	CcSEcCtD
Pentoxifylline—Headache—Capecitabine—colon cancer	0.00088	0.00148	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—colon cancer	0.000862	0.00145	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—colon cancer	0.000855	0.00144	CcSEcCtD
Pentoxifylline—Nausea—Capecitabine—colon cancer	0.000835	0.0014	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—colon cancer	0.000831	0.0014	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—colon cancer	0.000827	0.00139	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—colon cancer	0.000827	0.00139	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—colon cancer	0.000771	0.0013	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—colon cancer	0.000751	0.00126	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—colon cancer	0.00074	0.00125	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—colon cancer	0.000716	0.0012	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—colon cancer	0.000692	0.00116	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—colon cancer	0.000665	0.00112	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—colon cancer	0.00066	0.00111	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—colon cancer	0.000659	0.00111	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—colon cancer	0.000655	0.0011	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—colon cancer	0.000621	0.00105	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TOP1—colon cancer	0.000289	0.0184	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	0.000264	0.0169	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ODC1—colon cancer	0.000229	0.0146	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CHST5—colon cancer	0.000229	0.0146	CbGpPWpGaD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000209	0.0133	CbGpPWpGaD
Pentoxifylline—ADORA2A—HIF-2-alpha transcription factor network—EP300—colon cancer	0.000195	0.0125	CbGpPWpGaD
Pentoxifylline—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—colon cancer	0.000185	0.0118	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—PTGS2—colon cancer	0.000173	0.0111	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—CCND1—colon cancer	0.000157	0.01	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—CDKN1A—colon cancer	0.000152	0.00968	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—EP300—colon cancer	0.000144	0.00921	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—NRAS—colon cancer	0.000135	0.00861	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TYMS—colon cancer	0.000132	0.00841	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—MYC—colon cancer	0.000126	0.00802	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	0.000121	0.00775	CbGpPWpGaD
Pentoxifylline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000119	0.0076	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—KRAS—colon cancer	0.000116	0.00741	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—NRAS—colon cancer	0.000113	0.00721	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—NRAS—colon cancer	0.000104	0.00667	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DLC1—colon cancer	0.000103	0.00656	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TYMS—colon cancer	0.000102	0.00649	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—HRAS—colon cancer	9.87e-05	0.0063	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—KRAS—colon cancer	9.72e-05	0.00621	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LGR5—colon cancer	9.66e-05	0.00617	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DLC1—colon cancer	9.33e-05	0.00596	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—PPARG—colon cancer	9.33e-05	0.00595	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—KRAS—colon cancer	8.99e-05	0.00574	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	8.84e-05	0.00564	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LGR5—colon cancer	8.77e-05	0.0056	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DLC1—colon cancer	8.74e-05	0.00558	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DLC1—colon cancer	8.64e-05	0.00551	CbGpPWpGaD
Pentoxifylline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.28e-05	0.00529	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—HRAS—colon cancer	8.26e-05	0.00527	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LGR5—colon cancer	8.22e-05	0.00525	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LGR5—colon cancer	8.12e-05	0.00518	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—colon cancer	7.97e-05	0.00509	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—HRAS—colon cancer	7.64e-05	0.00488	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—PPARG—colon cancer	7.2e-05	0.0046	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AXIN2—colon cancer	6.94e-05	0.00443	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—colon cancer	6.88e-05	0.00439	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DLC1—colon cancer	6.75e-05	0.00431	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LGR5—colon cancer	6.34e-05	0.00405	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AXIN2—colon cancer	6.3e-05	0.00402	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FGFR3—colon cancer	6.13e-05	0.00391	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—EP300—colon cancer	6.1e-05	0.0039	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ABCB1—colon cancer	6.04e-05	0.00386	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—TYMS—colon cancer	5.93e-05	0.00379	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AXIN2—colon cancer	5.9e-05	0.00377	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AXIN2—colon cancer	5.83e-05	0.00372	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—BRAF—colon cancer	5.29e-05	0.00338	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—EP300—colon cancer	5.14e-05	0.00328	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	5.11e-05	0.00327	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—SRC—colon cancer	5e-05	0.00319	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—VEGFA—colon cancer	4.87e-05	0.00311	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—colon cancer	4.85e-05	0.0031	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—NRAS—colon cancer	4.81e-05	0.00307	CbGpPWpGaD
Pentoxifylline—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	4.78e-05	0.00305	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—EP300—colon cancer	4.71e-05	0.00301	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AXIN2—colon cancer	4.56e-05	0.00291	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—colon cancer	4.49e-05	0.00287	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	4.47e-05	0.00285	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TGFB1—colon cancer	4.47e-05	0.00285	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—colon cancer	4.37e-05	0.00279	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—colon cancer	4.32e-05	0.00276	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	4.25e-05	0.00272	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	4.25e-05	0.00272	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PPARG—colon cancer	4.2e-05	0.00268	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—KRAS—colon cancer	4.14e-05	0.00264	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	4.14e-05	0.00264	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	4.14e-05	0.00264	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	4.03e-05	0.00257	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	3.98e-05	0.00254	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CASP3—colon cancer	3.97e-05	0.00253	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	3.94e-05	0.00251	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—PIK3CA—colon cancer	3.8e-05	0.00243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CDKN1A—colon cancer	3.73e-05	0.00238	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	3.72e-05	0.00237	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	3.71e-05	0.00237	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	3.7e-05	0.00236	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—colon cancer	3.68e-05	0.00235	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	3.63e-05	0.00231	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	3.63e-05	0.00231	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—HRAS—colon cancer	3.52e-05	0.00225	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA7—colon cancer	3.48e-05	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—SRC—colon cancer	3.45e-05	0.00221	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	3.43e-05	0.00219	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	3.42e-05	0.00218	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—colon cancer	3.37e-05	0.00215	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NRAS—colon cancer	3.32e-05	0.00212	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTGS2—colon cancer	3.31e-05	0.00211	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	3.16e-05	0.00202	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—AKT1—colon cancer	3.11e-05	0.00198	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—colon cancer	3.03e-05	0.00193	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	2.91e-05	0.00186	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—KRAS—colon cancer	2.86e-05	0.00183	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	2.79e-05	0.00178	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—colon cancer	2.75e-05	0.00176	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PIK3CA—colon cancer	2.63e-05	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—HRAS—colon cancer	2.43e-05	0.00155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—colon cancer	2.15e-05	0.00137	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ODC1—colon cancer	2.11e-05	0.00134	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CHST5—colon cancer	2.11e-05	0.00134	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—colon cancer	2.03e-05	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGFR3—colon cancer	2e-05	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—colon cancer	1.84e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NRAS—colon cancer	1.84e-05	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGFR3—colon cancer	1.82e-05	0.00116	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—BRAF—colon cancer	1.73e-05	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGFR3—colon cancer	1.7e-05	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGFR3—colon cancer	1.68e-05	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—colon cancer	1.68e-05	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—colon cancer	1.67e-05	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NRAS—colon cancer	1.67e-05	0.00107	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—colon cancer	1.66e-05	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—colon cancer	1.6e-05	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—colon cancer	1.58e-05	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BRAF—colon cancer	1.57e-05	0.001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—colon cancer	1.57e-05	0.000999	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NRAS—colon cancer	1.57e-05	0.000999	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—colon cancer	1.55e-05	0.000987	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NRAS—colon cancer	1.55e-05	0.000987	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—colon cancer	1.52e-05	0.000972	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BRAF—colon cancer	1.47e-05	0.000939	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—colon cancer	1.46e-05	0.000929	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—colon cancer	1.46e-05	0.000929	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BRAF—colon cancer	1.45e-05	0.000928	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—colon cancer	1.44e-05	0.000918	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—colon cancer	1.43e-05	0.00091	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—colon cancer	1.41e-05	0.0009	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—colon cancer	1.36e-05	0.00087	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—colon cancer	1.35e-05	0.00086	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—colon cancer	1.35e-05	0.00086	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—colon cancer	1.35e-05	0.00086	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—colon cancer	1.33e-05	0.00085	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—colon cancer	1.32e-05	0.000844	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR3—colon cancer	1.32e-05	0.00084	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—colon cancer	1.31e-05	0.000836	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—colon cancer	1.3e-05	0.000828	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—colon cancer	1.26e-05	0.000806	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—colon cancer	1.25e-05	0.000798	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—colon cancer	1.24e-05	0.00079	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—colon cancer	1.22e-05	0.000781	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—colon cancer	1.22e-05	0.000781	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1A—colon cancer	1.22e-05	0.00078	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—colon cancer	1.21e-05	0.000772	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—colon cancer	1.21e-05	0.000772	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—colon cancer	1.19e-05	0.000759	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—colon cancer	1.19e-05	0.000759	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—colon cancer	1.18e-05	0.000752	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—colon cancer	1.16e-05	0.000742	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—colon cancer	1.15e-05	0.000732	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—colon cancer	1.15e-05	0.000731	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BRAF—colon cancer	1.14e-05	0.000725	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—colon cancer	1.14e-05	0.000725	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—colon cancer	1.13e-05	0.000722	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SRC—colon cancer	1.13e-05	0.000722	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—colon cancer	1.11e-05	0.000711	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1A—colon cancer	1.11e-05	0.000708	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—colon cancer	1.1e-05	0.000704	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—colon cancer	1.1e-05	0.000703	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—colon cancer	1.1e-05	0.000703	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—colon cancer	1.1e-05	0.000702	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—colon cancer	1.09e-05	0.000696	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—colon cancer	1.09e-05	0.000694	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—colon cancer	1.08e-05	0.000689	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—colon cancer	1.07e-05	0.000686	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—colon cancer	1.06e-05	0.000679	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—colon cancer	1.06e-05	0.000677	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—colon cancer	1.06e-05	0.000674	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—colon cancer	1.05e-05	0.000672	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—colon cancer	1.05e-05	0.000671	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—colon cancer	1.04e-05	0.000664	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1A—colon cancer	1.04e-05	0.000663	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1A—colon cancer	1.03e-05	0.000655	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SRC—colon cancer	1.03e-05	0.000655	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—colon cancer	1.01e-05	0.000647	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—colon cancer	1.01e-05	0.000645	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—colon cancer	1.01e-05	0.000645	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—colon cancer	1e-05	0.000638	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—colon cancer	9.99e-06	0.000638	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—colon cancer	9.91e-06	0.000633	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—colon cancer	9.88e-06	0.000631	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—colon cancer	9.87e-06	0.00063	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—colon cancer	9.77e-06	0.000624	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SRC—colon cancer	9.61e-06	0.000614	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—colon cancer	9.56e-06	0.00061	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SRC—colon cancer	9.5e-06	0.000606	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—colon cancer	9.36e-06	0.000598	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—colon cancer	9.36e-06	0.000598	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—colon cancer	9.25e-06	0.000591	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—colon cancer	9.25e-06	0.00059	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—colon cancer	9.2e-06	0.000587	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—colon cancer	9.18e-06	0.000586	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—colon cancer	9.14e-06	0.000583	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—colon cancer	9e-06	0.000574	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—colon cancer	8.84e-06	0.000564	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.69e-06	0.000555	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—colon cancer	8.61e-06	0.00055	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—colon cancer	8.6e-06	0.000549	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—colon cancer	8.6e-06	0.000549	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—colon cancer	8.59e-06	0.000549	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—colon cancer	8.52e-06	0.000544	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—colon cancer	8.51e-06	0.000543	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—colon cancer	8.5e-06	0.000543	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—colon cancer	8.49e-06	0.000542	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—colon cancer	8.42e-06	0.000538	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—colon cancer	8.32e-06	0.000531	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—colon cancer	8.32e-06	0.000531	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—colon cancer	8.29e-06	0.000529	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—colon cancer	8.21e-06	0.000524	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1A—colon cancer	8.02e-06	0.000512	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—colon cancer	7.96e-06	0.000508	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—colon cancer	7.96e-06	0.000508	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—colon cancer	7.86e-06	0.000502	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—colon cancer	7.81e-06	0.000498	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—colon cancer	7.81e-06	0.000498	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—colon cancer	7.63e-06	0.000487	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—colon cancer	7.55e-06	0.000482	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SRC—colon cancer	7.42e-06	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—colon cancer	7.31e-06	0.000467	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—colon cancer	7.23e-06	0.000461	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—colon cancer	7.22e-06	0.000461	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—colon cancer	7.22e-06	0.000461	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—colon cancer	7.14e-06	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—colon cancer	7.07e-06	0.000452	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—colon cancer	7.02e-06	0.000448	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—colon cancer	6.99e-06	0.000446	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.84e-06	0.000437	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—colon cancer	6.76e-06	0.000432	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—colon cancer	6.68e-06	0.000427	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—colon cancer	6.65e-06	0.000425	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—colon cancer	6.63e-06	0.000424	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—colon cancer	6.5e-06	0.000415	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—colon cancer	6.38e-06	0.000407	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—colon cancer	6.14e-06	0.000392	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—colon cancer	5.97e-06	0.000381	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—colon cancer	5.9e-06	0.000377	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.69e-06	0.000363	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—colon cancer	5.64e-06	0.00036	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—colon cancer	5.56e-06	0.000355	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMS—colon cancer	5.46e-06	0.000349	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—colon cancer	5.46e-06	0.000349	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—colon cancer	5.22e-06	0.000333	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—colon cancer	4.61e-06	0.000294	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.21e-06	0.000269	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—colon cancer	3.87e-06	0.000247	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—colon cancer	3.05e-06	0.000194	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—colon cancer	2.53e-06	0.000162	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—colon cancer	1.87e-06	0.00012	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—colon cancer	1.53e-06	9.77e-05	CbGpPWpGaD
